ViaDerma, Inc. (OTCMKTS: VDRM) is a dermatology-based healthcare company focused on the research, development and commercialization of proprietary topical skin-therapy products. Leveraging a patented elemental skin-therapy platform, the company designs formulations aimed at accelerating skin recovery, improving hydration and enhancing barrier function. Its product development process combines principles of biochemistry with clinical dermatology to address conditions ranging from dryness and irritation to minor wounds and abrasions.
The company’s flagship offerings include the Return2Life™ line of topical creams and lotions, which are formulated with a unique blend of essential minerals and electrolytes. These over-the-counter products are intended for immediate skin relief and longer-term restoration of the epidermal barrier. ViaDerma’s product portfolio is positioned to serve healthcare providers, first responders and retail consumers seeking scientifically driven skin-care solutions.
ViaDerma distributes its products primarily throughout the United States via multiple channels, including direct-to-consumer e-commerce platforms, partnerships with dermatology clinics and healthcare institutions, and select retail outlets. The company works closely with licensed practitioners and medical facilities to expand awareness of its formulations for use in both acute care settings and daily skin-care regimens.
Founded with the goal of translating cutting-edge skin-science into practical therapies, ViaDerma is led by a management team with backgrounds in pharmaceutical formulation, clinical research and dermatology. Headquartered in Florida, the company continues to advance its pipeline through ongoing R&D efforts, strategic collaborations and the pursuit of additional patent protections to support its long-term growth in the dermatological market.
AI Generated. May Contain Errors.
Free VDRM Stock Alerts